Skip to main content
OpenTrials
Completed

NCT Number: NCT02867930

Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography

The purpose of the study is to compare dexmedetomidine and ketofol to find a suitable alternative for moderate sedation in out-patient diagnostic trans-esophageal echocardiography.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Postgraduate Institute of Medical Education and Research

Chandigarh, 160012, India

About this study

Sample size was estimated based on previous studies with sedation in equally invasive procedures that in 2 groups difference in time to achieve Ramsay sedation scale was 0.8min.(In group dexmedetomidine 12.4 & group ketofol 13.2 with S.D of 0.8). The sample size came out to be 22 subjects per group at a power of 90 % & confidence interval of 95 %. For possible dropouts, it was decided to include 10% extra subjects so finally it was decided to include 25 subjects per group. (Total sample size 50 subjects)

Normality of quantitative data will be checked by measures of Kolmogorov Smirnov tests of normality. If data is normally distributed Student t-test will be applied for comparison of 2 groups. Mann-Whitney U-test will be used for statistical analysis of skewed continuous variables or ordered categorical data. Proportions will be compared using Chi square or Fisher's exact test whichever is applicable. Wilcoxon Signed rank test will be used for skewed data or for scores (time related variables). . For comparison (time related variables) of Hemodynamics Repeated Measure ANOVA will be applied. All statistical tests will be two-sided and will be performed at a significance level of α=0.05. Analysis will be conducted using SPSS for Windows

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Atrial septal defect/Valvular Heart disease (MS/MR/AS/AR)

Exclusion criteria

  • Atrial fibrillation with fast ventricular rate
  • Congestive cardiac failure
  • BMI > 30
  • Perforated viscus/active GI bleed
  • Esophageal stricture/tumor/laceration
  • H/o radiation to neck & mediastinum
  • H/o GI surgery or H/o dysphagia
  • Restriction of neck mobility
  • Active esophagitis/peptic ulcer disease
  • Symptomatic bradycardia
  • Seizure disorder
  • Coagulopathy/thrombocytopenia

Treatment and study plan

Dexmedetomidine

Drug

drug for moderate sedation in trans-esophageal echocardiography

Ketofol(ketamine+propofol)

Drug

drug for moderate sedation in trans-esophageal echocardiography

Primary outcomes

  1. Time taken to achieve adequacy of sedation before probe insertion.

    Time frame: maximum of 10 minutes

    Adequacy of sedation to be measured using Ramsay Sedation Scale (>=3 considered adequate for probe insertion)

Secondary outcomes

  1. Recovery time

    Time frame: Upto 30 minutes

    Time to achieve modified aldrete score >9

  2. Heart rate during procedure

    Time frame: every 5 minutes till end of procedure

    Heart rate in beats/min, , facial pain score as 0-10

  3. mean arterial pressure during procedure

    Time frame: every 5 minutes till end of procedure

    mean arterial pressure in mmHg,

  4. Oxygen saturation during procedure

    Time frame: every 5 minutes till end of procedure

    oxygen saturation in %

  5. End tidal carbondioxide during procedure

    Time frame: every 5 minutes till end of procedure

    End tidal carbon dioxide in mm Hg

Sponsors and collaborators

Lead sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh

Other

Registry information

Official study title

Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Out-patients Undergoing Diagnostic Trans-esophageal Echocardiography: A Randomized Controlled Trial

Acronym: KDTEE

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Aug 16, 2016
Registry last updated
Nov 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.